Predominance of sequence type 1 group with serotype VI among group B streptococci with reduced penicillin susceptibility identified in japan

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 11, 2011, Pages 2460-2464

  Kimura, Kouji ^a,b   Nagano, Noriyuki ^a,c   Nagano, Yukiko ^a   Wachino, Jun ichi ^a   Suzuki, Satowa ^a   Shibayama, Keigo ^a   Arakawa, Yoshichika ^a,b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Funabashi Municipal Medical Center   (Japan)

Author keywords

lactams; GBS; Multilocus sequence typing; Non susceptible

Indexed keywords

BETA LACTAM ANTIBIOTIC; DNA; PENICILLIN G;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA PURIFICATION; HUMAN; HUMAN TISSUE; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; STREPTOCOCCUS AGALACTIAE;

ALLELES; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; HUMANS; JAPAN; MULTILOCUS SEQUENCE TYPING; PENICILLIN RESISTANCE; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 80054692756     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr352     Document Type: Article

References (25)

1. Baker CJ. Group B streptococcal infections. In: Stevens DL, Kaplan EL, eds. Streptococcal Infections: Clinical Aspects, Microbiology, and Molecular Pathogenesis. Oxford, UK: Oxford University Press, 2000; 222-37.
2. Farley MM, Harvey RC, Stull T et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993; 328: 1807-11.
3. Heath PT, Balfour G, Weisner AM et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004; 363: 292-4.
4. Jackson LA, Hilsdon R, Farley MM et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995; 123: 415-20.
5. Schuchat A. Group B Streptococcus. Lancet 1999; 353: 51-6.
6. CDC. Prevention of perinatal group B streptococcal disease. MMWR Recomm Rep 2002; 51: 1-22.
7. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998; 11: 497-513.
8. Stoll BJ, Hansen N, Fanaroff AA et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347: 240-7.
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA, 2006.
10. Kimura K, Suzuki S, Wachino J et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008; 52: 2890-7.
11. Nagano N, Nagano Y, Kimura K et al. Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008; 52: 4258-67.
12. Nagano N, Kimura K, Nagano Y et al. Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from a sacral decubitus ulcer. J Antimicrob Chemother 2009; 64: 1326-8.
13. Dahesh S, Hensler ME, Van Sorge NM et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to b-lactam antibiotics. Antimicrob Agents Chemother 2008; 52: 2915-8.
14. Gaudreau C, Lecours R, Ismaïl J et al. Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J Antimicrob Chemother 2010; 65: 594-5.
15. Murayama SY, Seki C, Sakata H et al. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother 2009; 53: 2650-3.
16. Jones N, Bohnsack JF, Takahashi S et al. Multilocus sequence typing system for group B Streptococcus. J Clin Microbiol 2003; 41: 2530-6.
17. Kimura K, Wachino J, Kurokawa H et al. Practical disk diffusion test for detecting group B Streptococcus with reduced penicillin susceptibility. J Clin Microbiol 2009; 47: 4154-7.
18. Lin FC, Whiting A, Adderson E et al. Phylogenetic lineages of invasive and colonizing strains of serotype III group B streptococci from neonates: a multicenter prospective study. J Clin Microbiol 2006; 44: 1257-61.
19. Luan S, Granlund M, Sellin M et al. Multilocus sequence typing of Swedish invasive group B Streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 2005; 43: 3727-33.
20. Manning SD, Cody Springman A, Lehotzky E et al. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol 2009; 47: 1143-8.
21. Martins ER, Pessanha MA, Ramirez M et al. Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J Clin Microbiol 2007; 45: 3224-9.
22. Sun Y, Kong F, Zhao Z et al. Comparison of a 3-set genotyping system with multilocus sequence typing for Streptococcus agalactiae (group B Streptococcus). J Clin Microbiol 2005; 43: 4704-7.
23. Bisharat N, Crook DW, Leigh J et al. Hyperinvasive neonatal group B Streptococcus has arisen from a bovine ancestor. J Clin Microbiol 2004; 42: 2161-7.
24. Jones N, Oliver KA, Barry J et al. Enhanced invasiveness of bovinederived neonatal sequence type 17 group B Streptococcus is independent of capsular serotype. Clin Infect Dis 2006; 42: 915-24.
25. Van der Mee-Marquet N, Fourny L, Arnault L et al. Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites. J Clin Microbiol 2008; 46: 2906-11.